Concepedia

Georges von Degenfeld

GV

31

Publications

3.2K

Citations

24

H-Index

1994

Active since

Affiliations

Stanford University(Current)

Baxter (United States)

Bayer (Germany)

Ludwig-Maximilians-Universität München

University of California, San Francisco

Georges von Degenfeld is an author at Stanford University specializing in medicine, vascular biology, and biomedical engineering.

ORCID

Top concepts

Publications per year

1994–2019

31

Publications

31

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

Andreas Rembert Koczulla, Georges von Degenfeld, Christian Kupatt et al. · Journal of Clinical Investigation · 2003 · 833 citations · Full text

Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes

Galia Blum, Georges von Degenfeld, Milton Merchant et al. · Nature Chemical Biology · 2007 · 457 citations

, , +9

Collagen Matrices Enhance Survival of Transplanted Cardiomyoblasts and Contribute to Functional Improvement of Ischemic Rat Hearts

Ingo Kutschka, Ian Y. Chen, Theo Kofidis et al. · Circulation · 2006 · 201 citations · Full text

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins

Peter Boekstegers, Georges von Degenfeld, Wolfgang Giehrl et al. · Gene Therapy · 2000 · 155 citations

, , +9

Overexpression of Dimethylarginine Dimethylaminohydrolase Reduces Tissue Asymmetric Dimethylarginine Levels and Enhances Angiogenesis

Johannes Jacobi, Karsten Sydow, Georges von Degenfeld et al. · Circulation · 2005 · 144 citations

Rows per page

1–5 of 31